文献速递肝病

MAIT细胞在失代偿期肝硬化腹水中富集并高度活化

MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis.
PubMed 文献 · Hepatology · 2020-10-13

该研究比较了35例失代偿期肝硬化患者(含或不含自发性细菌性腹膜炎)的配对血液与腹水,以及健康对照和代偿期肝硬化患者血液。发现循环MAIT细胞显著减少,但腹水中MAIT细胞与多种固有免疫细胞显著增加,且腹水MAIT细胞呈组织驻留活化表型,对大肠杆菌或IL-12+IL-18刺激的功能反应增强;SBP时腹水MAIT细胞频率升高最显著。

要点

  • 失代偿期肝硬化患者循环MAIT细胞显著减少,但腹水中MAIT细胞显著增加。
  • 腹水MAIT细胞呈活化组织驻留表型,对大肠杆菌或IL-12+IL-18刺激功能反应增强。
  • SBP时腹水MAIT细胞频率在所有主要免疫细胞亚群中升高最显著。

核心结论

  • 失代偿期肝硬化患者循环MAIT细胞严重减少且表型受损,但腹膜MAIT细胞仍丰富、活化且功能高度活跃,并在SBP时进一步富集。

研究设计与样本

  • 收集35例失代偿期肝硬化患者(含或不含SBP)的配对外周血和腹水,用高维流式细胞术分析MAIT细胞表型和功能,并与24例健康对照和11例代偿期肝硬化患者的血液样本比较。

主要发现

  • 与对照相比,肝硬化患者循环MAIT细胞严重减少。
  • 腹水中MAIT细胞与CD14+CD16+单核细胞、固有淋巴样细胞和自然杀伤细胞一起显著增加。
  • 腹水中多种促炎细胞因子和趋化因子水平高于血浆。
  • 腹膜MAIT细胞呈活化组织驻留表型,对大肠杆菌或IL-12+IL-18刺激的功能反应强于循环MAIT细胞。
  • SBP期间,腹膜MAIT细胞频率在所有主要免疫细胞亚群中升高最显著。

临床怎么用

  • 腹膜MAIT细胞可能成为失代偿期肝硬化及SBP患者免疫干预策略的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with advanced liver cirrhosis have an increased susceptibility to infections. As part of the cirrhosis-associated immune dysfunction, mucosal-associated invariant T (MAIT) cells, which have the capacity to respond to bacteria, are severely diminished in circulation and liver tissue. However, MAIT cell presence and function in the peritoneal cavity, a common anatomical site for infections in cirrhosis, remain elusive. In this study, we deliver a comprehensive investigation of the immune compartment present in ascites of patients with decompensated liver cirrhosis, and focus especially on MAIT cells. APPROACH AND RESULTS: To study this, matched peripheral blood and ascites fluid were collected from 35 patients with decompensated cirrhosis, with or without spontaneous bacterial peritonitis (SBP). MAIT cell phenotype and function were analyzed using high-dimensional flow cytometry, and the obtained data were compared with the blood samples of healthy controls (n = 24) and patients with compensated cirrhosis (n = 11). We found circulating MAIT cells to be severely decreased in patients with cirrhosis as compared with controls. In contrast, in ascites fluid, MAIT cells were significantly increased together with CD14+ CD16+ monocytes, innate lymphoid cells, and natural killer cells. This was paralleled by elevated levels of several pro-inflammatory cytokines and chemokines in ascites fluid as compared with plasma. Peritoneal MAIT cells displayed an activated tissue-resident phenotype, and this was corroborated by increased functional responses following stimulation with E. coli or interleukin (lL)-12 + IL-18 as compared with circulating MAIT cells. During SBP, peritoneal MAIT cell frequencies increased most among all major immune cell subsets, suggestive of active homing of MAIT cells to the site of infection. CONCLUSIONS: Despite severely diminished MAIT cell numbers and impaired phenotype in circulation, peritoneal MAIT cells remain abundant, activated, and highly functional in decompensated cirrhosis and are further enriched in SBP. This suggests that peritoneal MAIT cells could be of interest for immune-intervention strategies in patients with decompensated liver cirrhosis and SBP.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Niehaus CE, Strunz B, Cornillet M, et al. MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis. Hepatology. 2020. PMID: 32012321. doi:10.1002/hep.31153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。